格隆汇11月20日丨华康洁净(301235.SZ)公布，公司于近日参与了"柯桥未来医学中心净化系统项目"的投 标，招标单位为绍兴柯桥未来之城医学项目建设有限公司。2025年11月19日，浙江省公共资源交易服务 平台发布了相关中标候选人公示。中标价：175,687,785.00元。 ...

华康洁净（301235）(301235.SZ)公告，公司近日参与了"柯桥未来医学中心净化系统项目"的投标，招标 单位为绍兴柯桥未来之城医学项目建设有限公司。根据相关中标候选人公示，公司为第一名中标候选 人，中标价1.76亿元。 ...

人民财讯11月20日电，华康洁净（301235）11月20日公告，预中标柯桥未来医学中心净化系统项目，中 标价1.76亿元，中标工期240日历天。 ...

"洁净所能"： 四层核心内涵筑牢品牌护城河 华翱此次发布的 "洁净所能" 品牌口号，以简洁有力的文字承载丰富价值，从业务定位、生态布 局、服务理念到全球战略，构建起完整的价值闭环，成为彰显品牌核心竞争力的生动注脚。 1. 锚定核心赛道，彰显专业基因 "洁净所能" 首先明确了华翱的核心业务方向——专注于洁净工程核心材料研发与供应。自2013年 创立以来，华翱始终聚焦洁净领域，构建了集"产品设计研发、生产制造、销售服务"于一体的全产 业链体系，为生物医药、航天航空、精密制造、医院、光伏、新能源、食品工程等先进制造业提供 核心支撑，而"洁净所能"的口号，精准传递出华翱作为 "洁净专家" 的专业底色。 1 10 月 16 日，第 67 届秋季药机博览会现场，华翱控股集团有限公司（以下简称 "华翱"）正 式官宣全新品牌口号 "洁净所能"。与此同时，华翱内部员工曾婧瑶以品牌代言人身份亮相， 携全新品牌视觉海报重磅登场。这一动作，既是华翱深耕洁净领域十余载的实力见证，更凭 借 "服务 + 美学" 的双重突破，重新定义了洁净行业的品牌价值与视觉表达体系。 华翱展位现场 华翱品牌代言人 2. 凸显全产业链优势，构建产业闭环 从 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 格隆汇9月25日丨华康洁净(301235.SZ)公布，公司于2025年8月28日在创业板信息披露网站巨潮资讯网 上披露了《关于项目预中标的提示性公告》。近日，公司收到招标人浙江滨海新区投资发展集团有限公 司发出的《中标通知书》，确认公司为"浙江省肿瘤医院绍兴院区(浙江滨海医院)新建工程医用净化专 项工程"项目的中标供应商。项目预计总金额为13,627.0305万元，占公司2024年度经审计营业收入的 7.98%，项目的履行不影响公司业务的独立性，如本项目签订正式合同并顺利实施，预计会对公司未来 年度的净利润产生积极的影响。 ...

华康洁净公告，公司中标"浙江省肿瘤医院绍兴院区(浙江滨海医院)新建工程医用净化专项工程"项目， 中标金额为1.36亿元，占公司2024年度经审计营业收入的7.98%。该项目为综合三甲医院，总建筑面积 约50万平方米，总投资约50亿，公司负责净化系统专项工程设施采购及安装。项目的履行预计会对公司 未来年度的净利润产生积极的影响。 ...

Core Viewpoint - The company has been awarded a contract for a medical service construction project, which is expected to positively impact its future net profit and revenue [1] Group 1: Project Details - The project is estimated to have a total investment of 142 million yuan and the winning bid is 131 million yuan [1] - The project includes the purification engineering of special departments such as the surgical center and ICU, radiation protection engineering, medical gas engineering, and smart hospital construction [1] - The construction site is located in the Jinlin community of the Xiaoxiang Street, Qilin District, with a construction period of 150 calendar days [1] Group 2: Financial Impact - The project is expected to account for 7.67% of the company's audited operating income for the year 2024 [1] - Successful implementation of the project is anticipated to have a positive effect on the company's net profit in future years [1]

Core Viewpoint - Huakang Clean (301235.SZ) has won the bid for the procurement project of special departments for the People's Hospital of Donglin New District, Fuzhou, with a confirmed bid amount of 50,070,669.35 yuan [1] Group 1 - The company participated in the bidding for the procurement project organized by the Public Service Bureau of Donglin New District [1] - The bid result was officially announced on September 10, 2025, by the Jiangxi Provincial Public Resources Trading Platform [1] - The confirmed bid amount is approximately 50 million yuan [1]

Core Viewpoint - Huakang Clean (301235.SZ) has won a bid for the procurement project of special departments at Fuzhou East New District People's Hospital, with a contract amount of 50.07 million yuan, representing 2.93% of the company's audited revenue for the fiscal year 2024 [1] Group 1 - The company participated in the bidding for the procurement project organized by the Fuzhou East New District Public Service Bureau [1] - The bid results were announced on September 10, 2025, confirming the company as the successful supplier [1] - The contract amount of 50.07 million yuan is significant for the company's financials, accounting for 2.93% of its projected revenue for 2024 [1]

Core Insights - The company reported a significant increase in revenue and net profit for the first half of 2025, with total revenue reaching 835 million yuan, a year-over-year growth of 50.73%, and a net profit of 19 million yuan, up 273.48% [1][2] Revenue Breakdown - The purification system integration business led the growth, achieving revenue of 712 million yuan in H1 2025, reflecting a year-over-year increase of 59.95% [2] - Medical consumables sales generated revenue of 71 million yuan, down 8.56% year-over-year, but there are expectations for recovery as the company integrates market resources [2] Quarterly Performance - In Q2 2025, the company achieved revenue of 540 million yuan, a year-over-year increase of 66.45%, indicating a positive trend in business performance [1][2] Profitability Metrics - The gross profit margin for H1 2025 was 31.51%, a decrease of 5.12 percentage points year-over-year, while the net profit margin improved to 2.40%, an increase of 4.34 percentage points [2] Order Backlog and Growth Potential - As of June 30, 2025, the company had a substantial order backlog of 3.827 billion yuan, including 2.537 billion yuan in medical special orders, indicating strong growth momentum [3] - The electronic purification sector is expected to become a second growth curve for the company, with recent project wins showcasing industry recognition of its clean technology [3] Future Revenue Projections - Revenue forecasts for 2025 to 2027 are 2.817 billion, 3.676 billion, and 4.728 billion yuan, with respective year-over-year growth rates of 64.9%, 30.5%, and 28.6% [4]